Intravenous Lidocaine in Open Lung Resection Surgery
Status:
Completed
Trial end date:
2020-05-15
Target enrollment:
Participant gender:
Summary
Management of postoperative pain in 2020 remains a challenge for anesthesiologists in the
perioperative period. Lidocaine is an amide local anesthetic, it is one of the oldest
adjuvant analgesics and is known to possess analgesic, anti-hyperalgesic and
anti-inflammatory properties. Lidocaine is proven to be as effective as epidural analgesia in
colorectal surgery.
However, no study has evaluated the effect of a continuous lidocaine infusion for open lung
resection in the post-operative period. The present study aims to evaluate the influence of
IV lidocaine given during and 24 hours after surgery, on pain scores, opioid consumption, and
possible benefits on patient outcome via the opioid-sparing effect in open thoracic surgery